Alkermes, Inc. (ALKS)

EMG114 (< 20) Submitted: 5/20/08 9:24 PM : Start Price: $13.71 ALKS Score: 20.61

There is high expectations in some circles about this company since many are predicting stronger sales of its schizophrenia drug Risperdal Consta. Not only that but, Alkermes' diabetes drug Exenatide LAR will get attention at a diabetes conference in June since competing drug candidates are thought to be less effective and thus, will not be featured in the conference. All this can boost ALKS' sales and stocks...

Report this Post Replies: 0 | Reply